About Orphan Reach
Orphan Reach is a company based in Milton Keynes (United Kingdom) founded in 2012 was acquired by Emmes in May 2021.. Orphan Reach offers products and services including Biostatistics Services, Clinical Data Management, Clinical Trial Management, Pharmacovigilance Services, and Endpoint Solutions. Orphan Reach operates in a competitive market with competitors including Zenas BioPharma, AllStripes, Prime Global, Agility Clinical and CTI Clinical Trial, among others.
- Headquarter Milton Keynes, United Kingdom
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name The Emmes Company, Llc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Orphan Reach
Orphan Reach offers a comprehensive portfolio of products and services, including Biostatistics Services, Clinical Data Management, Clinical Trial Management, Pharmacovigilance Services, and Endpoint Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Statistical support for clinical trial design and analysis
Management of data in clinical research studies
Oversight of trial execution and regulatory affairs
Monitoring and reporting of adverse events in trials
Tools for assessing trial endpoints and patient outcomes
Funding Insights of Orphan Reach
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Orphan Reach
Orphan Reach has secured backing from 1 investor. Prominent investors backing the company include Emmes. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Outsourced contract research organization services are provided to clients.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Orphan Reach
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Orphan Reach
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Orphan Reach Comparisons
Competitors of Orphan Reach
Orphan Reach operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zenas BioPharma, AllStripes, Prime Global, Agility Clinical and CTI Clinical Trial, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Clinical development services for autoimmune and rare diseases are provided.
|
|
| domain | founded_year | HQ Location |
Provider of information to patients and communities with the medical data for rare diseases
|
|
| domain | founded_year | HQ Location |
Medical communication solutions are provided for healthcare professionals.
|
|
| domain | founded_year | HQ Location |
CRO with a special focus on orphan drug development
|
|
| domain | founded_year | HQ Location |
Provides clinical trials, consulting, and regulatory services in healthcare sectors.
|
|
| domain | founded_year | HQ Location |
Biotech company focused on developing therapies for rare diseases, with a current focus on Hirschsprung disease
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Orphan Reach
When was Orphan Reach founded?
Orphan Reach was founded in 2012.
Where is Orphan Reach located?
Orphan Reach is headquartered in Milton Keynes, United Kingdom.
What does Orphan Reach do?
Orphan Reach is a CRO focussed on rare diseases and orphan drugs development. They offer early development services (regulatory strategy planning, orphan drug designation, FDA and EMA Meeting Preparation and Representation etc.,), natural history studies (studies that follow a group of people over time who have or are at risk of developing a specific disease), clinical trial management solutions (project management, biostatistics, regulatory affairs etc.,), patient home support and post marketing surveillance services. They claim to have special focus on patient recruitment and retention for orphan drug trials. They also offer their services for pediatric drugs and rare diseases. They claim to have access to patients with rare diseases in more than 100 countries world-wide.
Who are the top competitors of Orphan Reach?
Orphan Reach's top competitors include Zenas BioPharma, AllStripes and Prime Global.
What products or services does Orphan Reach offer?
Orphan Reach offers Biostatistics Services, Clinical Data Management, Clinical Trial Management, Pharmacovigilance Services, and Endpoint Solutions.
Who are Orphan Reach's investors?
Orphan Reach has 1 investor. Key investors include Emmes.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.